(2026). Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Bayesian Reanalysis of Early Remdesivir for the Treatment of COVID-19 in Outpatients with High Risk of Progression to Severe Disease."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Bayesian Reanalysis of Early Remdesivir for the Treatment of COVID-19 in Outpatients with High Risk of Progression to Severe Disease."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.